Literature DB >> 18671743

Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.

A Bailey1, A Metaxas, J H Yoo, T McGee, I Kitchen.   

Abstract

Understanding the neurobiology of the transition from initial drug use to excessive drug use has been a challenge in drug addiction. We examined the effect of chronic 'binge' escalating dose cocaine administration, which mimics human compulsive drug use, on behavioural responses and the dopaminergic system of mice and compared it with a chronic steady dose (3 x 15 mg/kg/day) 'binge' cocaine administration paradigm. Male C57BL/6J mice were injected with saline or cocaine in an escalating dose paradigm for 14 days. Locomotor and stereotypy activity were measured and quantitative autoradiographic mapping of D(1) and D(2) receptors, dopamine transporters and D(2)-stimulated [(35)S]GTPgammaS binding was performed in the brains of mice treated with this escalating and steady dose paradigm. An initial sensitization to the locomotor effects of cocaine followed by a dose-dependent increase in the duration of the locomotor effect of cocaine was observed in the escalating but not the steady dose paradigm. Sensitization to the stereotypy effect of cocaine and an increase in cocaine-induced stereotypy score was observed from 3 x 20 to 3 x 25 mg/kg/day cocaine. There was a significant decrease in D(2) receptor density, but an increase in D(2)-stimulated G-protein activity and dopamine transporter density in the striatum of cocaine-treated mice, which was not observed in our steady dose paradigm. Our results document that chronic 'binge' escalating dose cocaine treatment triggers profound behavioural and neurochemical changes in the dopaminergic system, which might underlie the transition from drug use to compulsive drug use associated with addiction, which is a process of escalation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671743     DOI: 10.1111/j.1460-9568.2008.06369.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

1.  Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.

Authors:  A P Piras; Y Zhou; S D Schlussman; A Ho; M J Kreek
Journal:  Neuroscience       Date:  2010-05-07       Impact factor: 3.590

Review 2.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

3.  Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.

Authors:  M Schwendt; J F McGinty
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

4.  NOX1/NADPH Oxidase Promotes Synaptic Facilitation Induced by Repeated D2 Receptor Stimulation: Involvement in Behavioral Repetition.

Authors:  Nozomi Asaoka; Masakazu Ibi; Hikari Hatakama; Koki Nagaoka; Kazumi Iwata; Misaki Matsumoto; Masato Katsuyama; Shuji Kaneko; Chihiro Yabe-Nishimura
Journal:  J Neurosci       Date:  2021-02-09       Impact factor: 6.167

Review 5.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

6.  Influence of cocaine administration patterns on dopamine receptor regulation.

Authors:  Stéphanie Puig; Nicolas Marie; Nadia Benturquia; Florence Noble
Journal:  Psychopharmacology (Berl)       Date:  2014-02-21       Impact factor: 4.530

7.  CRF1 receptor-deficiency induces anxiety-like vulnerability to cocaine.

Authors:  Nadège Morisot; Mark J Millan; Angelo Contarino
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530

8.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

9.  Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Authors:  Gregory T Collins; Yen Nhu-Thi Truong; Beth Levant; Jianyong Chen; Shaomeng Wang; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2011-01-05       Impact factor: 4.530

10.  Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.

Authors:  Fernando Caravaggio; Sofia Raitsin; Philip Gerretsen; Shinichiro Nakajima; Alan Wilson; Ariel Graff-Guerrero
Journal:  Biol Psychiatry       Date:  2013-03-27       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.